Tumor-LN-oC | 12-month follow-up meeting

May 13, 2022

Asphalion is participating in the 12-month follow-up meeting of Horizon 2020 project Tumor-LN-oC that is currently taking place in Eindhoven, Netherlands, on May 12 and 13. During the meeting, Asphalion expert Marta Morales is presenting the results of the regulatory roadmap prepared as part of the activities to develop the regulatory strategy of the Tumor-LN-oC platform.

All 11 partners of the project are attending the meeting, with representatives from microfluidics, cell biology, cancer biology, physics, computer programming and the regulatory affairs field. This has been the second meeting of the Tumor-LN-oC consortium, allowing the participants to meet in person to review a year’s progress since the beginning of the project.

The EU-funded Tumor-LN-oC project proposes the development and validation of a TRL 5 tumor-lymph node-on-chip (Tumor-LN-oC) platform composed of 3D tissue models and microfluidic chips which will connect surgically removed human primary tumors and LN tissue from the same lung cancer patient. This will serve as a “biological twin” of the patient and will allow to study the interaction of primary tumors with LNs for individual patients.

For a complete overview of the project, we invite you to have a look at the website: https://tumor-ln-oc.eu/

For further information, you can also contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

HORIZON | siNPAIN 6th progress meeting

The objective of this project is to create a siRNA-combined advanced therapy, which will allow a more personalised treatment for the different stages of osteoarthritis. All siNPAIN partners are working hard to develop an efficient therapy to improve the quality of life of those affected by osteoarthritis, a chronic joint condition that affects more and more people every year.

PragmaTIL | Second Annual Meeting

Asphalion expert Núria García participated last week in the 2nd Annual PragmaTIL Consortium Meeting in Amsterdam, hosted by the Netherlands Cancer Institute (NKI). This two-day

EVENT | RAPS EuroConvergence 2025

At ASPHALION we are pleased to announce our participation in RAPS EuroConvergence 2025, one of the premier regulatory affairs events in Europe. This year’s conference

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting